Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- &agr; converting enzyme (TACE)

Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- &agr; converting enzyme (TACE)

US Patent 6740649 · Granted May 25, 2004

Estimated economic value: $101,956,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CGRP antagonist compounds2025
CGRP antagonist compounds2025
Opioid receptor ligands and methods of using and making same2024
Pyrimidinone derivatives as CDC7 inhibitors2023
Opioid receptor ligands and methods of using and making same2021
ROR γ modulators2021
ROR γ modulators2021
Pyrimidinone derivatives as Cdc7 inhibitors2021
Thienopyrimidine inhibitors of atypical protein kinase C2021
Preparation and uses of pyrimidinone derivatives2021
Heterocyclic compounds useful as modulators of TNF alpha2020
Heterocyclic compounds useful as modulators of TNF alpha2020